Medyra’s international manufacturing operations are vital to our global mission of providing accessible and affordable oncology treatments. These facilities are equipped with the latest technological advancements, allowing us to produce a range of anti-cancer formulations that adhere to global regulatory standards, including WHO and cGMP guidelines. We have strategically positioned our operations in key markets, ensuring timely access to our life-saving drugs for patients and healthcare systems around the world.

In addition to cutting-edge production capabilities, our international facilities focus on maintaining a seamless supply chain that supports efficient distribution across the globe. This enables Medyra to swiftly deliver oncology treatments to those in need, regardless of geographical boundaries.